Good grief, even after the huge reverse split, our stock continues to go down. Come on management do something that will increase the stock price now, PLEASE. You guy's are getting paid and I'm losing alot, almost all, of my investment.Stop the downtrend now.
In a 10/31/13 press release from the NIH it says that they hope to launch human clinical trials of a RSV vaccine as soon as clinical grade material can be manufactured, a process that takes approximately 18- 24 months. It looks as if the competition is far, far, far away from us. Not to worry.
In a press release from Reuters today on the bird flu vaccines I came away with the following:
1. Novavax, not Novartis , was the company that was featured in the article in the New England Journal of Medicine. This to me indicates that we are seen as top dog on this front.
2.In that article a spokesman from BARDA, Robin Robinson says that using Novavax's technology the 1st doses of the H7N9 could be produced within 12 weeks in the emergence of a pandemic, 50 million doses within 4 months, and hundreds of millions within just 6 months. How many doses can Novartis put out in the same timeframe?